Our observation that elevated ETS1 expression is particularly pronounced in the presence of the BRAFV600E mutation supports the hypothesis that these two factors may synergistically enhance tumor progression by over-activating downstream signaling pathways linked to cellular proliferation and migration. This evidence concerns the gene ETS1 and neoplasm.